157 results
Page 4 of 8
8-K
EX-1.1
iuca6697h2 lus
6 Feb 20
Ziopharm Oncology Announces Pricing of Public Offering of Common Stock
9:21am
8-K
EX-99.1
matmr
6 Feb 20
Ziopharm Oncology Announces Pricing of Public Offering of Common Stock
9:21am
8-K
EX-99.1
kbdsk5l
4 Feb 20
Ziopharm Oncology Announces Proposed Public Offering of Common Stock
9:48pm
8-K
EX-99.1
nye9gtaazljxzfye6nl
25 Nov 19
Ziopharm Oncology Presents Encouraging Clinical Data for ControlledIL-12 for the Treatment of Recurrent Glioblastoma
9:00am
8-K
EX-10.1
9e5x1 zymt9
26 Sep 19
Entry into a Material Definitive Agreement
9:07am
8-K
EX-4.1
m92m uuadyvoqh
13 Sep 19
Entry into a Material Definitive Agreement
9:01am
8-K
EX-10.1
xc53yd1gwe3oec02nq
13 Sep 19
Entry into a Material Definitive Agreement
9:01am
8-K
EX-10.3
lhdw99x66rc79
1 Aug 19
Ziopharm Oncology Announces $45 Million
4:31pm
8-K
EX-10.1
pr4obx f0ynrmnwpe
1 Aug 19
Ziopharm Oncology Announces $45 Million
4:31pm
8-K
EX-4.1
8ts8p2u as3
1 Aug 19
Ziopharm Oncology Announces $45 Million
4:31pm
S-3ASR
EX-1.2
xzwmy3f8p50
21 Jun 19
Automatic shelf registration
5:31pm
8-K
EX-4.1
l3sc7vv
13 Nov 18
Ziopharm Oncology Announces $50 Million Private Placement
8:39am